Inhibiting EGFR was shown to exert neuroprotection in AD [147] highlighting it as a novel potential target for AD [148] overall suggesting that EGFR plays a neurotoxic role in AD pathogenesis [149]. Here, EGFR is linked to Alzheimer disease.